首页|《本草纲目·百病主治药》研究述评

《本草纲目·百病主治药》研究述评

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
"百病主治药"位于《本草纲目》第三、四卷,是李时珍对历代医家辨病与辨证选药精华的总结,有重要的临床应用价值和文献价值.以往对《本草纲目》的研究以药物各论为主,对"百病主治药"的研究较少.近年来,学者对其重视度日益提高,因此文章对"百病主治药"研究成果和存在的问题进行论述,望为日后此部分的研究提供参考.
Review on the research of Compendium of Materia Medica·Indicative Medicines for Various Diseases
Located in volumes Ⅲ and Ⅳ of the Compendium of Materia Medica,the'indicative medicines for various diseases'was LI Shizhen's summary of the essence of disease differentiation and drug selection by doctors in previous dynasties.It has important clinical application value and literature value.In the past,the research on Compendium of Materia Medica mainly focused on the various theories of drugs,and the research on'indicative medicines for various diseases'was less.In recent years,scholars have paid more and more attention to it.Therefore,this paper discusses the research results and existing problems of'indicative medicines for various diseases',hoping to provide reference for future research in this part.

Compendium of Materia MedicaIndicative medicines for various diseasesUniversal medicine for all diseasesProgressLiterature researchDisease related drugsValue

林艳华、宋咏梅

展开 >

山东中医药大学中医文献与文化研究院,济南 250355

《本草纲目》 百病主治药 诸疾通用药 进展 文献研究 以病类药 价值

2020年中医药古籍文献和特色技术传承专项项目

GZY-KJS-2020-029

2024

中华中医药杂志
中华中医药学会

中华中医药杂志

CSTPCD北大核心
影响因子：1.135
ISSN：1673-1727
年,卷(期)：2024.39(2)
  • 34